Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 20 of 100
Leadership
Crypto Correspondent
By
Coins2Day Editors
May 31, 2023
Commentary
Why the underestimated economic burden of rare diseases could be costing the U.S. trillions of dollars
By
Giacomo Chiesi
May 25, 2023
Health
A Colorado panel of medical and pharmacy experts will decide whose medicine to make affordable this summer
By
Markian Hawryluk
and
KFF Health News
May 22, 2023
Commentary
Sanofi CEO: ‘Europe’s lead in life sciences R&D is eroding–but co-localized hubs could allow it to keep up’
By
Paul Hudson
May 17, 2023
Health
First-of-its-kind drug for rare form of Lou Gehrig’s disease gets FDA approval
By
Matthew Perrone
and
The Associated Press
April 25, 2023
Health
Crypto Correspondent
By
Macarius Mwinisungee Donneyong
,
Ximena Oyarzún-González
and
The Conversation
April 21, 2023
Health
How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
By
Arthur Allen
and
KFF Health News
April 13, 2023
Commentary
A zombie apocalypse isn’t likely–but a fungal outbreak is
By
David Angulo
April 11, 2023
Newsletters
U.S. women need better birth control. So why is this contraceptive company ‘on life support?’
By
Maria Aspan
and
Kinsey Crowley
April 5, 2023
Health
A 79-year-old ‘white collar drug dealer’ who sold opioids to pharmacies is going to serve only 2 years in prison
By
Bob Van Voris
and
Bloomberg
March 8, 2023
Health
After capping the price of insulin, Colorado sets its sights on EpiPen copays
By
Helen Santoro
and
Kaiser Health News
February 27, 2023
Health
Mark Cuban has been taking on the drug industry. But which one?
By
Darius Tahir
and
Kaiser Health News
February 17, 2023
Health
The first drug to have even a limited impact on Alzheimer’s just got FDA approval. ‘This drug is not a cure.’
By
Matthew Perrone
and
The Associated Press
January 6, 2023
Health
Alzheimer’s drug approval by FDA ‘rife with irregularities,’ Congress finds after 18-month investigation
By
The Associated Press
December 30, 2022
Health
ALS patients face dilemma over drug’s $158K price tag: ‘I’m not going to spend all my money on this’
By
Matthew Perrone
and
The Associated Press
December 18, 2022
Most Popular
Big Tech
The Chan Zuckerberg Initiative cut 70 jobs as the Meta CEO’s philanthropy goes all in on mission to 'cure or prevent...
By
Sydney Lake
Success
U.S. Olympic gold medalist went from $200,000-a-year sponsorship at 20 years old to $12-an-hour internship by 30
By
Orianna Rosa Royle
Economy
'I just don't have a good feeling about this': Top economist Claudia Sahm says the economy quietly shifted and...
By
Eleanor Pringle